DCF — AIKEN REGIONAL MEDICAL CENTER
Enterprise Value: $-42.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-42.4M
Enterprise Value
$-18.8M
PV of Cash Flows
$-23.6M
PV of Terminal Value
$-38.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $208.3M | $1.0M | 0.0% | $-7.8M | $-7.1M |
| Year 2 | $214.6M | $3.2M | 1.0% | $-5.9M | $-4.9M |
| Year 3 | $221.0M | $5.5M | 2.0% | $-3.9M | $-2.9M |
| Year 4 | $227.7M | $6.8M | 3.0% | $-3.1M | $-2.1M |
| Year 5 | $234.5M | $7.6M | 3.0% | $-2.8M | $-1.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-42.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$202.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.00023573695627692248
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5